Conversely, miR-125b inhibition in sensitive cells upregulated cyclin D1 and N-cadherin and downregulated E-cadherin at the mRNA and protein levels, indicating that EMT was promoted in oxaliplatin-sensitive HCC cells (Figs. 3a–c). The gene discussed is CDH2; the disease is hepatocellular carcinoma.